Literature DB >> 10672874

Prior topical anesthesia reduces time to full cycloplegia in Chinese.

A W Siu1, A C Sum, D T Lee, K W Tam, S W Chan.   

Abstract

PURPOSE: To investigate the effect of prior anesthesia on the time to full cycloplegia in young Chinese subjects.
METHODS: The amplitude of accommodation was monitored over a 50-minute interval after the application of 1% cyclopentolate hydrochloride with a pretreatment of 0.4% benoxinate (oxybuprocaine) or 0.9% saline solution (control). Using a nonlinear mathematical model, the rate of accommodative loss (k) and the time required for 95% of total cycloplegia (T95%) were determined.
RESULTS: Statistical analysis revealed a significantly faster rate of accommodative loss (P < .0001) after prior anesthesia (0.129 +/- 0.05) compared with the controls (0.103 +/- 0.04). T95% was noted at 26.43 +/- 10.22 minutes after prior anesthesia, which was significantly shorter (P < .0001) than that after the saline treatment (35.28 +/- 16.51 minutes).
CONCLUSIONS: Prior application of topical anesthetic can shorten the time to full cycloplegia for people, such as the Chinese, with dark irides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10672874     DOI: 10.1016/s0021-5155(99)00113-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  2 in total

1.  Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1.

Authors:  Helena M van Minderhout; Maurits V Joosse; Diana C Grootendorst; Nicoline E Schalij-Delfos
Journal:  Acta Ophthalmol       Date:  2021-10-20       Impact factor: 3.988

2.  Onset and duration of cycloplegic action of 1% cyclopentolate - 1% tropicamide combination.

Authors:  Samuel Kyei; Alfred Asiem Nketsiah; Kofi Asiedu; Agnes Awuah; Andrew Owusu-Ansah
Journal:  Afr Health Sci       Date:  2017-09       Impact factor: 0.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.